Submitted by Anonymous (not verified) on 5 November 2025 - 16:02
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Revision: 2, Status: Authorised